Morning Briefing
Summaries of health policy coverage from major news organizations
CVS Agrees To Pay $5M To Settle Medicare Drug False Advertising Claims
CVS Caremark has agreed to pay $5 million to settle claims of false advertising on the prices of certain drugs offered in Medicare drug plans, the FTC announced Thursday. The money will be used to reimburse beneficiaries who paid more than expected for the drugs.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
